FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of ...

Abivax presents third quarter 2024 key financial informationPARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: ...

Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") today announced financial results for the third quarter and nine-month period ended September 30, 2024. Highlights ...

Speaking to members of the media ahead of today’s match, Powell said every game of the series was now like a final to the ...

Good morning and welcome to ImmuCell Corporation Reports Third Quarter September 30, 2024, Unaudited Financial Results Conference Call. All participants will be in listen-only mode. After today’s ...

Siddiq’s words, however, indicate that, despite CMC objections, they are on the way ... by loading costs onto everyone who ...

Robust firmonertinib monotherapy activity in front-line EGFR PACC mutant NSCLC including in patients with brain metastasesTop-line pivotal data ...

Linda Marban; President, Chief Executive Officer, Director; Capricor Therapeutics Inc ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...

An in-depth weekly look at NFL matchups and how they’ll affect your fantasy football lineup, with players you should start, ...

Barapukuria Coal Mining Company Limited (BCMCL) is at risk of being forced to halt production as its storage yard is ...